27562210|t|Polyanionic carbosilane dendrimers prevent hepatitis C virus infection in cell culture
27562210|a|Hepatitis C virus (HCV) infection is a major biomedical problem worldwide. Although new direct antiviral agents (DAAs) have been developed for the treatment of chronic HCV infection, the potential emergence of resistant virus variants and the difficulties to implement their administration worldwide make the development of novel antiviral agents an urgent need. Moreover, no effective vaccine is available against HCV and transmission of the virus still occurs particularly when prophylactic measures are not taken. We used a cell-based system to screen a battery of polyanionic carbosilane dendrimers (PCDs) to identify compounds with antiviral activity against HCV and show that they inhibit effective virus adsorption of major HCV genotypes. Interestingly, one of the PCDs irreversibly destabilized infectious virions. This compound displays additive effect in combination with a clinically relevant DAA, sofosbuvir. Our results support further characterization of these molecules as nanotools for the control of hepatitis C virus spread.
27562210	0	23	Polyanionic carbosilane	T103	UMLS:C1610990
27562210	24	34	dendrimers	T103	UMLS:C1563732
27562210	43	70	hepatitis C virus infection	T038	UMLS:C4288963
27562210	74	86	cell culture	T058	UMLS:C0007585
27562210	87	120	Hepatitis C virus (HCV) infection	T038	UMLS:C4288963
27562210	132	142	biomedical	T091	UMLS:C1879848
27562210	143	150	problem	T033	UMLS:C0033213
27562210	234	243	treatment	T058	UMLS:C0087111
27562210	255	268	HCV infection	T038	UMLS:C4288963
27562210	297	312	resistant virus	T005	UMLS:C1444092
27562210	417	433	antiviral agents	T103	UMLS:C0003451
27562210	473	480	vaccine	T103	UMLS:C0042210
27562210	502	505	HCV	T005	UMLS:C0220847
27562210	510	522	transmission	T038	UMLS:C0242781
27562210	530	535	virus	T005	UMLS:C0042776
27562210	567	588	prophylactic measures	T033	UMLS:C0481566
27562210	655	678	polyanionic carbosilane	T103	UMLS:C1610990
27562210	679	689	dendrimers	T103	UMLS:C1563732
27562210	691	695	PCDs	T103	UMLS:C1563732
27562210	709	742	compounds with antiviral activity	T033	UMLS:C0243095
27562210	751	754	HCV	T005	UMLS:C0220847
27562210	792	808	virus adsorption	T038	UMLS:C1721019
27562210	818	821	HCV	T005	UMLS:C0220847
27562210	859	863	PCDs	T103	UMLS:C1563732
27562210	901	908	virions	T017	UMLS:C0042760
27562210	996	1006	sofosbuvir	T103	UMLS:C2976303
27562210	1104	1121	hepatitis C virus	T005	UMLS:C0220847